Management of Prolonged QT Interval

Initial Assessment and Risk Stratification

The American College of Cardiology recommends obtaining baseline ECG and measuring QTc interval using appropriate correction formulas, with the Fridericia formula preferred over Bazett formula, especially at higher heart rates 2
Normal QTc values are <430 ms for males and <450 ms in females; QTc >500 ms or an increase of >60 ms from baseline significantly increases the risk of torsades de pointes 2
The American College of Cardiology suggests checking serum electrolytes, particularly potassium and magnesium levels, and correcting any abnormalities immediately 2, 3
Risk factors for QT prolongation include advanced age, female sex, structural heart disease, bradycardia, and concomitant use of multiple QT-prolonging medications 2, 3

For QTc 450-480 ms (Grade 1), the American College of Cardiology recommends identifying and addressing reversible causes including medications and electrolyte abnormalities 2
For QTc 481-500 ms (Grade 2), the American College of Cardiology suggests implementing more frequent ECG monitoring, correcting electrolyte abnormalities aggressively, and considering dose reduction of QT-prolonging medications 2, 3
For QTc >500 ms or increase >60 ms from baseline (Grade 3-4), the American College of Cardiology recommends temporarily discontinuing causative medications immediately, correcting electrolyte abnormalities urgently, and continuing ECG monitoring until QTc normalizes 2, 3

The American College of Cardiology recommends administering 2g IV magnesium sulfate regardless of serum magnesium level as the initial drug of choice 3, 2
The American Heart Association suggests considering non-synchronized defibrillation if hemodynamically unstable 4, 2
For bradycardia-induced torsades, the American College of Cardiology recommends implementing temporary overdrive pacing (with short-term pacing rates of 90-110 bpm) 3, 2
The American College of Cardiology suggests using IV isoproterenol titrated to heart rates >90 bpm when temporary pacing is not immediately available 3, 2

The American College of Cardiology recommends beta blockers as the first-line treatment for congenital long QT syndrome, particularly for long QT syndrome type 1 1, 5
The American College of Cardiology suggests that beta blockers may be beneficial in reducing the frequency of arrhythmia recurrence in patients with acquired QT prolongation, particularly when associated with myocardial ischemia 4
The American College of Cardiology recommends avoiding QT-prolonging medications in patients with known long QT syndrome unless there is no suitable alternative 1, 5

The American College of Cardiology recommends maintaining normal potassium and magnesium balance, especially during situations that promote depletion such as diuretic use or gastrointestinal illness 1, 3
The American College of Cardiology suggests reducing fever with antipyretics in patients with long QT syndrome type 2, as fever has been reported to prolong the QT interval 1

The American College of Cardiology recommends obtaining baseline ECG and electrolytes before starting QT-prolonging cancer therapies 3
The American College of Cardiology suggests repeating ECG 7 days after initiation of therapy and monitoring QTc periodically during treatment 3
The American College of Cardiology recommends stopping treatment if QTc exceeds 500 ms 3

The American College of Cardiology suggests that young women with LQT2 and QTc >500 ms are at increased risk of sudden cardiac arrest, especially in the postpartum period 1, 5
The American College of Cardiology recommends considering primary prevention ICD placement or wearable cardioverter-defibrillator in high-risk patients 1, 5

The American College of Cardiology recommends performing periodic ECG monitoring for patients on QT-prolonging medications 2
The American College of Cardiology suggests that exercise testing can be beneficial for monitoring adequacy of beta-blocker therapy, particularly in school-aged patients 1, 5

The American College of Cardiology recommends manual verification of automated QT interval measurements, especially with abnormal baseline ECGs 1, 5
The American College of Cardiology suggests that patients with normal QTc intervals can still have long QT syndrome (10-36% of genotype-positive patients have QTc ≤440 ms) 1, 5
The American Heart Association recommends avoiding medications that block AV node (adenosine, calcium channel blockers, digoxin, beta-blockers) in patients with pre-excited atrial fibrillation as they may cause paradoxical increase in ventricular response 4